A detailed history of Oracle Alpha Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Oracle Alpha Inc. holds 6,295 shares of ARVN stock, worth $116,331. This represents 0.47% of its overall portfolio holdings.

Number of Shares
6,295
Previous 11,895 47.08%
Holding current value
$116,331
Previous $490 Million 46.92%
% of portfolio
0.47%
Previous 0.63%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$36.38 - $52.31 $203,728 - $292,936
-5,600 Reduced 47.08%
6,295 $260 Million
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $168,790 - $503,515
11,895 New
11,895 $490 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $983M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.